Keyword: Johnson & Johnson
News
10.04.2018
- Johnson & Johnson, the US market’s largest healthcare company, and its talc supply partner Imerys Talc America have lost their first lawsuit involving the deadly cancer...
News
23.03.2018
- Britain’s largest pharmaceutical producer GlaxoSmithKline (GSK) has estimated that its costs related to Brexit, the country’s leaving the EU, could run as high as £70 million over...
News
06.02.2018
- Pharmaceutical companies’ interest in buying consumer health businesses is waning, with more players interested in shedding the activities than acquiring them, reports suggest...
News
25.01.2018
- US healthcare giant Johnson & Johnson has just been handed its second defeat in patent litigation this month. On Jan. 23, a US appeals court hearing J&J’s challenge to a lower...
News
24.01.2018
- Sanofi is boosting its presence in blood disorders through the acquisition of Bioverativ, the former hemophilia business of major US biotech Biogen, which was spun out in February...
News
22.01.2018
- Chinese companies are said to be taking great interest in the diabetes care business Johnson & Johnson may put up for sale. The news agency Reuters, citing “five people with direct...
News
19.01.2018
- A report from the US Food and Drug Administration (FDA) published in Pharmacoepidemiology & Drug Safety has confirmed the safety profile and effectiveness of the anticoagulant...
News
12.12.2017
- In the fourth of three lawsuits heard by US courts over the risks of the blockbuster blood thinner Xarelto to date, a jury in Philadelphia, Pennsylvania, last week ordered Bayer...
